ArticleThe Journal of investigative dermatology2019

MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma.

Anupama Sahoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.